Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, et al.
Journal of Clinical and Translational Hepatology (2017) Vol. XX, Iss. XX, pp. 1-14
Open Access | Times Cited: 24

Showing 24 citing articles:

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Richard D. Kim, Debashis Sarker, Tim Meyer, et al.
Cancer Discovery (2019) Vol. 9, Iss. 12, pp. 1696-1707
Open Access | Times Cited: 196
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives
Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, et al.
Cancer Letters (2023) Vol. 556, pp. 216066-216066
Closed Access | Times Cited: 38
Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps
Silvia Di Giacomo, Óscar Briz, María J. Monte, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 3, pp. 623-634
Closed Access | Times Cited: 55
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
Wei-Chieh Huang, Shiao-Lin Tung, Yao‐Li Chen, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 59
Fisetin Inhibits Autophagy in HepG2 Cells via PI3K/Akt/mTOR and AMPK Pathway
Kiruthika Sundarraj, Azhwar Raghunath, Lakshmikanthan Panneerselvam, et al.
Nutrition and Cancer (2020) Vol. 73, Iss. 11-12, pp. 2502-2514
Closed Access | Times Cited: 42
Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a N-Nitrosodiethylamine-Induced Mice Model of Hepatocellular Carcinoma
Mohamed Nasr, Ahmed Y. Kira, Sameh Saber, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 9, pp. 4758-4769
Closed Access | Times Cited: 11
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
Emanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Nutrients (2020) Vol. 12, Iss. 10, pp. 3101-3101
Open Access | Times Cited: 28
NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation
Meilin Liu, Wei Song, Xi Du, et al.
ACS Medicinal Chemistry Letters (2018) Vol. 9, Iss. 12, pp. 1253-1257
Open Access | Times Cited: 22
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis
Emanuele Rinninella, Marco Cintoni, Pauline Raoul, et al.
Internal and Emergency Medicine (2020) Vol. 16, Iss. 5, pp. 1341-1356
Open Access | Times Cited: 18
The Pivotal Role of Long Noncoding RNA RAB5IF in the Proliferation of Hepatocellular Carcinoma via LGR5 Mediated β-Catenin and c-Myc Signaling
Ja Il Koo, Hyo‐Jung Lee, Ji Hoon Jung, et al.
Biomolecules (2019) Vol. 9, Iss. 11, pp. 718-718
Open Access | Times Cited: 13
Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention
Petra Grbčić, Elitza Markova-Car, Mirela Sedić
Current Medicinal Chemistry (2019) Vol. 27, Iss. 39, pp. 6611-6627
Closed Access | Times Cited: 12
TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma
Shufang Xiang, Juan Li, Mei Zhang
International Journal of Hyperthermia (2024) Vol. 41, Iss. 1
Open Access | Times Cited: 1
A novel oncolytic adenovirus inhibits hepatocellular carcinoma growth
Yuhuan Bai, Xiaojing Yun, Yan Xue, et al.
Journal of Zhejiang University SCIENCE B (2019) Vol. 20, Iss. 12, pp. 1003-1013
Open Access | Times Cited: 10
ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma
Jiale Lv, Jinxia Liu, Mingbin Xiao, et al.
Pathology - Research and Practice (2018) Vol. 214, Iss. 9, pp. 1356-1361
Closed Access | Times Cited: 9
Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma
Min Yao, Miao Fang, Wenjie Zheng, et al.
Hepatoma Research (2018) Vol. 4, Iss. 7, pp. 30-30
Open Access | Times Cited: 7
Calreticulin nuclear translocalization alleviates CaM/CaMKII/CREB signaling pathway to enhance chemosensitivity in HDAC inhibitor-resistant hepatocellular carcinoma cells
Yi‐Sheng Liu, Yuchun Chang, Wei‐Wen Kuo, et al.
Aging (2022) Vol. 14, Iss. 12, pp. 5097-5115
Open Access | Times Cited: 4
Risk factors of microvascular invasion in patients with hepatocellular carcinoma
Yan Zhang, Wanjing Yang, Jingli Ren
Biomedical Research - India (2018) Vol. 29, Iss. 4
Open Access | Times Cited: 4

Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study


Liwen Guo, Jiaping Zheng, Jun Luo, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 11071-11087
Open Access | Times Cited: 4
Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts
Barbara Schellhaas, Deike Strobel, Miriam Stumpf, et al.
European Journal of Gastroenterology & Hepatology (2018) Vol. 30, Iss. 12, pp. 1422-1427
Closed Access | Times Cited: 3
Nanomedicinal delivery systems for intelligent treatment of hepatocellular carcinoma
Sarah Ama Baidoo, Emmanuel Konadu Sarkodie, Kofi Oti Boakye‐Yiadom, et al.
Journal of Drug Delivery Science and Technology (2019) Vol. 53, pp. 101152-101152
Closed Access | Times Cited: 2
Bioinformatic Deconstruction of Differentially Expressed Sequence Tags in Hepatocellular Carcinoma Based on Artificial Neural Network
Jing Yi, Zhili Wen, Youwen Hu
Contrast Media & Molecular Imaging (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 1
Sangramento pós-exodôntico em pacientes em fila de transplante hepático: análise retrospectiva
Janaína Braga Medina
(2018)
Open Access
An incidentally Diagnosed Hepatocellular Carcinoma That Exhibited Unusual Metastasis
Meryem DEMİR
Turkish Journal of Oncology (2020)
Open Access
Genomics and Interventional Oncology in Primary Liver Cancer
Ryan Slovak, Meaghan Dendy Case, Hyun S. Kim
Digestive Disease Interventions (2020) Vol. 04, Iss. 01, pp. 053-059
Closed Access
Page 1

Scroll to top